Download presentation
Presentation is loading. Please wait.
1
DNA Repair Polymorphisms and Treatment Outcomes of Patients with Malignant Mesothelioma Treated with Gemcitabine-Platinum Combination Chemotherapy Nina Erčulj, BSc, Viljem Kovač, PhD, MD, Julija Hmeljak, PhD, Alenka Franko, PhD, MD, Metoda Dodič-Fikfak, PhD, MD, Vita Dolžan, PhD, MD Journal of Thoracic Oncology Volume 7, Issue 10, Pages (October 2012) DOI: /JTO.0b013e d31 Copyright © 2012 International Association for the Study of Lung Cancer Terms and Conditions
2
FIGURE 1 Overall survival in the function of combination of CRP levels and XRCC1 Arg399Gln genotype in malignant mesothelioma patients treated with gemcitabine-platinum combination chemotherapy (N = 109). CRP, C-reactive protein; CRPhigh, above-median CRP level; CRPlow, under-median CRP level. Journal of Thoracic Oncology 2012 7, DOI: ( /JTO.0b013e d31) Copyright © 2012 International Association for the Study of Lung Cancer Terms and Conditions
Similar presentations
© 2024 SlidePlayer.com Inc.
All rights reserved.